Metraipolis › archive › dc_4bf1f33ae094

Cardiac specific knock-down of peroxisome proliferator activated receptor α prevents fasting-induced cardiac lipid accumulation and reduces perilipin 2 — Europe PMC PMID:35259201

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35259201
DOI
10.1371/journal.pone.0265007
License (as archived)
CC0-1.0
Archived
2026-10-31T08:03:18.417Z
SHA-256 of the archived text
d3b58835aceebbddc4393686b0b954411b7625f5d2253a526af36fce09aa8827
Stable URL of this page
https://metraipolis.com/documento/dc_4bf1f33ae094

How to cite

Cardiac specific knock-down of peroxisome proliferator activated receptor α prevents fasting-induced cardiac lipid accumulation and reduces perilipin 2 — Europe PMC PMID:35259201 — Europe PMC (en), https://europepmc.org/article/MED/35259201 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_4bf1f33ae094 (Metraipolis archive dc_4bf1f33ae094, sha256 d3b58835aceebbddc4393686b0b954411b7625f5d2253a526af36fce09aa8827)
BibTeX
@misc{dc4bf1f33ae094,
  title = {Cardiac specific knock-down of peroxisome proliferator activated receptor α prevents fasting-induced cardiac lipid accumulation and reduces perilipin 2 — Europe PMC PMID:35259201},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35259201},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_4bf1f33ae094; sha256 d3b58835aceebbddc4393686b0b954411b7625f5d2253a526af36fce09aa8827},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35259201. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

While fatty acid metabolism is altered under physiological conditions, alterations can also be maladaptive in diseases such as diabetes and heart failure. Peroxisome Proliferator Activated Receptor α (PPARα) is a transcription factor that regulates fat metabolism but its role in regulating lipid storage in the heart is unclear. The aim of this study is to improve our understanding of how cardiac PPARα regulates cardiac health and lipid accumulation. To study the role of cardiac PPARα, tamoxifen inducible cardiac-specific PPARα knockout mouse (cPPAR-/-) were treated for 5 days with tamoxifen and then studied after 1-2 months. Under baseline conditions, cPPAR-/- mice appear healthy with normal body weight and mortality is not altered. Importantly, cardiac hypertrophy or reduced cardiac function was also not observed at baseline. Mice were fasted to elevate circulating fatty acids and induce cardiac lipid accumulation. After fasting, cPPAR-/- mice had dramatically lower cardiac triglyceride levels than control mice. Interestingly, cPPAR-/- hearts also had reduced Plin2, a key protein involved in lipid accumulation and lipid droplet regulation, which may contribute to the reduction in cardiac lipid accumulation. Overall, this suggests that a decline in cardiac PPARα may blunt cardiac lipid accumulation by decreasing Plin2 and that independent of differences in systemic metabolism a decline in cardiac PPARα does not seem to drive pathological changes in the heart.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-03-08).
Identificativi: PMID 35259201 · PMCID PMC8903264 · DOI 10.1371/journal.pone.0265007.
Descrittori MeSH principali: PPAR alpha; Fasting.
Pagina: https://europepmc.org/article/MED/35259201 — https://doi.org/10.1371/journal.pone.0265007. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-31T07:48:34.684Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.